UAB "GL Pharma Vilnius" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,004,910 |
| 167,485 |
| 48,053 |
| 38,756 |
| 6,459 |
| 100.00 |
| 3.86 |
| 228,021 |
| 57,406 |
| 4,875 |
| 279,769 |
| 2023 |
|---|
| 1,101,340 |
| 183,557 |
| 16,822 |
| 10,947 |
| 1,825 |
| 100.00 |
| 0.99 |
| 238,968 |
| 84,054 |
| 5,341 |
| 325,685 |
| 2024 |
|---|
| 1,483,931 |
| 251,088 |
| 108,511 |
| 89,761 |
| 15,188 |
| 36.24 |
| 6.05 |
| 328,729 |
| 110,892 |
| 3,109 |
| 431,889 |
Register and
explore Okredo data| 2024 |
|---|
| 1,483,931 |
| 251,088 |
| 108,511 |
| 89,761 |
| 15,188 |
| 36.24 |
| 6.05 |
| 328,729 |
| 110,892 |
| 3,109 |
| 431,889 |
Register and
explore Okredo data2024
Turnover (€)
1,483,931 €
35 % *
Sales per employee (€)
251,088 €37 % *
Profit before tax (€)
108,511 €545 % *
Net Profit (€)
89,761 €720 % *
Profit per employee (€)
15,188 €732 % *
Total profitability (%)
36.24 %
-63.76 % *
Net profitability (%)
6.05 %511.11 % *
Equity (€)
328,729 €38 % *
Amounts Payable And Liabilities (€)
110,892 €
32 % *
Non-current Assets (€)
3,109 €
-42 % *
CurrentAssets (€)
431,889 €33 % *